These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of an inhalational model of invasive aspergillosis. Steinbach WJ; Benjamin DK; Trasi SA; Miller JL; Schell WA; Zaas AK; Foster WM; Perfect JR Med Mycol; 2004 Oct; 42(5):417-25. PubMed ID: 15552643 [TBL] [Abstract][Full Text] [Related]
3. Murine model of invasive pulmonary aspergillosis following an earlier stage, noninvasive Aspergillus infection. Nawada R; Amitani R; Tanaka E; Niimi A; Suzuki K; Murayama T; Kuze F J Clin Microbiol; 1996 Jun; 34(6):1433-9. PubMed ID: 8735094 [TBL] [Abstract][Full Text] [Related]
4. Virulence of Aspergillus fumigatus double mutants lacking restriction and an alkaline protease in a low-dose model of invasive pulmonary aspergillosis. Smith JM; Tang CM; Van Noorden S; Holden DW Infect Immun; 1994 Dec; 62(12):5247-54. PubMed ID: 7960101 [TBL] [Abstract][Full Text] [Related]
5. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Kaur S; Gupta VK; Thiel S; Sarma PU; Madan T Clin Exp Immunol; 2007 May; 148(2):382-9. PubMed ID: 17335555 [TBL] [Abstract][Full Text] [Related]
6. Neuroimmune Responses in a New Experimental Animal Model of Cerebral Aspergillosis. Sullivan BN; Baggett MA; Guillory C; Jones M; Steele C mBio; 2022 Oct; 13(5):e0225422. PubMed ID: 36040029 [TBL] [Abstract][Full Text] [Related]
7. Invasive pulmonary aspergillosis: high incidence of disseminated intravascular coagulation in fatal cases. Lai CC; Liaw SJ; Lee LN; Hsiao CH; Yu CJ; Hsueh PR J Microbiol Immunol Infect; 2007 Apr; 40(2):141-7. PubMed ID: 17446962 [TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis: clinical and pathological features of a new animal model. Spreadbury CL; Krausz T; Pervez S; Cohen J J Med Vet Mycol; 1989; 27(1):5-15. PubMed ID: 2666632 [TBL] [Abstract][Full Text] [Related]
9. Disseminated aspergillosis due to Aspergillus flavus in an experimental model: efficacy of azole therapy. Kaliamurthy J; Geraldine P; Thomas PA Mycoses; 2003 Jun; 46(5-6):174-82. PubMed ID: 12801358 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. Cenci E; Mencacci A; Del Sero G; Bacci A; Montagnoli C; d'Ostiani CF; Mosci P; Bachmann M; Bistoni F; Kopf M; Romani L J Infect Dis; 1999 Dec; 180(6):1957-68. PubMed ID: 10558953 [TBL] [Abstract][Full Text] [Related]
11. Investigation of Aspergillus flavus in animal virulence. Lan H; Wu L; Sun R; Yang K; Liu Y; Wu J; Geng L; Huang C; Wang S Toxicon; 2018 Apr; 145():40-47. PubMed ID: 29481813 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. Wiederhold NP; Kontoyiannis DP; Chi J; Prince RA; Tam VH; Lewis RE J Infect Dis; 2004 Oct; 190(8):1464-71. PubMed ID: 15378439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]